Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Viyash Scientific Ltd

NSE: VIYASH · BSE: 512529 · Pharmaceuticals & Biotechnology · 13 announcements

Share price
₹244.35
Market cap
₹10,791 Cr
Revenue (annual)
₹3,420 Cr
Net profit (annual)
₹177.3 Cr
P/E (TTM)
63.0×Sector 50.4×
Promoter holding
61.31%+0.00% QoQ
FII holding
4.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

12:26 IST BSE
Employee Stock Options

Viyash Scientific Employee Stock Options

Viyash Scientific allotted 1,107,309 ESOP shares at exercise prices of ₹86 and ₹101. Paid-up capital rose to ₹88.33 Crore post-allotment.

18:50 IST BSE
Merger & Restructuring

Viyash Scientific Merger & Restructuring

Viyash Scientific Limited announced receipt of Italian regulatory approval for its subsidiary Alivira Animal Health's acquisition of BioForLife Italia S.r.l. The transaction completion timeline is extended.

18:41 IST BSE
Acquisition

Viyash Scientific Acquisition

Viyash Scientific Limited received Italian regulatory approval for its proposed 100% acquisition of BioForLife Italia S.r.l., with the completion timeline now extended by two months.

11:13 IST BSE
Employee Stock Options

Viyash Scientific Employee Stock Options

Viyash Scientific Limited allotted 6,12,773 equity shares following the exercise of options under its ESOP 2020 and 2026 schemes. The company's paid-up capital increased to Rs. 88.10 Crore.